Pallas Capital Advisors’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $944K | Buy |
7,361
+518
| +8% | +$66.4K | 0.04% | 346 |
|
2025
Q1 | $606K | Buy |
6,843
+1,114
| +19% | +$98.6K | 0.03% | 415 |
|
2024
Q4 | $500K | Buy |
5,729
+72
| +1% | +$6.28K | 0.02% | 365 |
|
2024
Q3 | $470K | Buy |
5,657
+176
| +3% | +$14.6K | 0.02% | 374 |
|
2024
Q2 | $622K | Buy |
5,481
+252
| +5% | +$28.6K | 0.03% | 278 |
|
2024
Q1 | $496K | Buy |
5,229
+32
| +0.6% | +$3.04K | 0.02% | 283 |
|
2023
Q4 | $479K | Sell |
5,197
-1,513
| -23% | -$140K | 0.03% | 274 |
|
2023
Q3 | $365K | Hold |
6,710
| – | – | 0.02% | 271 |
|
2023
Q2 | $388K | Buy |
+6,710
| New | +$388K | 0.02% | 212 |
|